Tiernan J. Mulrooney, Ph.D. - Publications
Affiliations: | 2012 | Tumor Biology | Georgetown University, Washington, DC |
Area:
Immunology, Molecular Biology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2016 | Boudreau JE, Mulrooney TJ, Le Luduec JB, Barker E, Hsu KC. KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV. Journal of Immunology (Baltimore, Md. : 1950). 196: 3398-410. PMID 26962229 DOI: 10.4049/Jimmunol.1502469 | 0.414 | |||
2015 | Mulrooney TJ, Zhang AC, Goldgur Y, Boudreau JE, Hsu KC. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding. Journal of Immunology (Baltimore, Md. : 1950). 195: 1242-50. PMID 26109640 DOI: 10.4049/Jimmunol.1500243 | 0.54 | |||
2013 | Mulrooney TJ, Posch PE, Hurley CK. DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells Journal of Leukocyte Biology. 94: 301-313. PMID 23715743 DOI: 10.1189/Jlb.0213093 | 0.501 | |||
2009 | VandenBussche CJ, Mulrooney TJ, Frazier WR, Dakshanamurthy S, Hurley CK. Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule Genes and Immunity. 10: 162-173. PMID 19005473 DOI: 10.1038/Gene.2008.91 | 0.519 | |||
2008 | Mulrooney TJ, Hou L, Steiner NK, Chen M, Belle I, Ng J, Hurley CK. Promoter variants of KIR2DL5 add to diversity and may impact gene expression. Immunogenetics. 60: 287-94. PMID 18461314 DOI: 10.1007/S00251-008-0273-7 | 0.418 | |||
Show low-probability matches. |